UNSPSC 51112306: Treosulfan

This classification denotes an alkylsulfonate compound with the molecular formula C6H14O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CO61ER3EPI, chemically known as 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate, (s-(r*,r*))- (9ci) but more generally known as treosulfan, which bears US NIH Compound Identifier 9296. European Medicines Agency schedules Treosulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11235MIG.

UNSPSC 51112306 Treosulfan is a Commodity code for a chemotherapy agent used primarily in hematologic malignancy treatment and bone marrow transplant conditioning regimens. State and local governments procure this pharmaceutical through health systems, hospital networks, and state Medicaid programs that serve patient populations requiring stem cell transplantation or certain leukemia and lymphoma treatments. The code captures acquisition of treosulfan as a finished pharmaceutical product, typically through competitive bidding among manufacturers and pharmaceutical distributors, often leveraging group purchasing organization (GPO) contracts or state cooperative purchasing agreements to negotiate volume pricing.

The source material contains no posted state or local procurement opportunities under this code. Without recent solicitation activity to characterize, issuing-body mix, geographic concentration, or representative notice examples cannot be determined from available records.